tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Balance Sheet

Compare
238 Followers

NewAmsterdam Pharma Company Balance Sheet

NewAmsterdam Pharma Company's total assets for Q3 2025 were $786.43M, a decrease of -3.52% from the previous quarter. NAMS total liabilities were $58.36M for the fiscal quarter, a 59.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 864.62M$ 347.10M$ 478.50M$ 67.99M$ 139.87M
Total Liabilities
$ 107.12M$ 58.70M$ 48.43M$ 11.36M$ 12.41M
Total Equity Gross Minority
$ 757.50M$ 288.39M$ 430.07M$ 56.63M$ 127.46M
Other Metrics
Currency in USD

NewAmsterdam Pharma Company Debt to Assets